iTeos Therapeutics, Inc.
ITOSNASDAQHealthcare
$10.15
+$0.02(+0.20%)
Market Cap$448684810
P/E Ratio—
52W High$17.63
52W Low$4.8
iTeos Therapeutics, Inc.（ITOS）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ITOS · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $35.00M | $12.60M | $267.63M | $344.77M | $0.00M |
| Cost of Revenue | $1.24M | $0.90M | $0.81M | $0.61M | $0.54M |
| Gross Profit | $33.76M | $11.70M | $266.82M | $344.16M | ($0.54M) |
| Gross Margin %(computed) | 96.46% | 92.87% | 99.70% | 99.82% | — |
| Operating Expenses | |||||
| R&D Expenses | $145.45M | $113.30M | $97.36M | $59.37M | $29.90M |
| G&A Expenses | $49.08M | $50.40M | $43.95M | $40.51M | $15.34M |
| Total Operating Expenses | $193.29M | $162.80M | $140.49M | $99.26M | $44.70M |
| Operating Income | ($159.53M) | ($151.10M) | $126.32M | $244.90M | ($45.24M) |
| Operating Margin %(computed) | -455.79% | — | 47.20% | 71.03% | — |
| Interest Income | $30.87M | $31.77M | $11.36M | $0.08M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($120.34M) | ($109.03M) | $148.74M | $256.46M | ($38.09M) |
| Income Tax Expense | $14.07M | $3.61M | $52.08M | $41.94M | ($0.06M) |
| Net Income | ($134.41M) | ($112.64M) | $96.65M | $214.52M | ($38.03M) |
| Net Margin %(computed) | -384.04% | -894.34% | 36.11% | 62.22% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.32 | $-3.15 | $2.72 | $6.10 | $-1.24 |
| Wtd Avg Shares | 40.47M | 35.76M | 35.55M | 35.18M | 35.04M |
| EBITDA | ($121.82M) | ($111.66M) | $148.38M | $257.08M | ($37.84M) |
| EBITDA Margin %(computed) | -348.07% | -886.53% | 55.44% | 74.56% | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解iTeos Therapeutics, Inc.
关于iTeos Therapeutics, Inc.（ITOS）损益表
iTeos Therapeutics, Inc.（ITOS）损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年，ITOS实现营收$0.04B，毛利润$0.03B（毛利率96.46%），净利润($0.13B)（净利率-384.04%）。
常见问题
ITOS · 4 问iTeos Therapeutics, Inc.（ITOS）2024财年营收为$0.04B，同比up177.9%。
ITOS revenueITOS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09